Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Return on Equity: 2011-2025

Historic Return on Equity for Rockwell Medical (RMTI) over the last 15 years, with Sep 2025 value amounting to -0.17%.

  • Rockwell Medical's Return on Equity fell 12.00% to -0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.17%, marking a year-over-year decrease of 12.00%. This contributed to the annual value of -0.02% for FY2024, which is 47.00% up from last year.
  • Per Rockwell Medical's latest filing, its Return on Equity stood at -0.17% for Q3 2025, which was down 134.33% from -0.07% recorded in Q2 2025.
  • Rockwell Medical's Return on Equity's 5-year high stood at 28.25% during Q1 2022, with a 5-year trough of -4.79% in Q4 2021.
  • Over the past 3 years, Rockwell Medical's median Return on Equity value was -0.23% (recorded in 2024), while the average stood at -0.37%.
  • As far as peak fluctuations go, Rockwell Medical's Return on Equity skyrocketed by 2,923bps in 2022, and later tumbled by 2,924bps in 2023.
  • Quarterly analysis of 5 years shows Rockwell Medical's Return on Equity stood at -4.79% in 2021, then surged by 356bps to -1.24% in 2022, then spiked by 83bps to -0.41% in 2023, then soared by 39bps to -0.02% in 2024, then declined by 12bps to -0.17% in 2025.
  • Its last three reported values are -0.17% in Q3 2025, -0.07% for Q2 2025, and -0.01% during Q1 2025.